Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abnormal, Adaptimmune, addressed, Africa, Albumin, alliance, altogether, Arabian, Asia, Baxter, Bayer, benchmark, benchmarking, beta, bio, BioMarin, birth, Bluebird, Broadly, CAG, chemistry, children, China, Clustered, cognition, Cooley, crescent, CRISPR, curative, descent, destruction, DHFR, easily, enlarged, error, essential, excessive, exon, Fabry, forego, Gaucher, Genzyme, GlaxoSmithKline, globin, GSK, HD, heart, HTT, Huntingtin, Hurler, hydroxyurea, immunogenicity, incidence, inconclusive, Interspaced, Iran, iron, JHU, knock, knocking, labor, Lentigen, lipase, lipoprotein, listed, LPLD, matrix, Mediterranean, mistake, mutant, neutralizing, Nordisk, Novo, occurrence, onset, overload, Palindromic, Peninsula, plasma, Pompe, prioritize, priority, procedure, recycling, RegenX, regularly, SCD, Schematic, sector, shape, skeleton, skipping, Southeast, spleen, stream, substance, suspension, thalassemia, trait, unchanged, unforeseen, uniQure, unwanted, XI
Removed:
account, activator, Amsterdam, anin, appeal, appealed, applicability, assure, Bill, bradykinesia, charged, chronic, clear, consummation, converted, convertible, crushed, currency, cutting, cytotoxic, decade, Decadron, decision, denominated, diagnosed, dismissing, dollar, dopamine, downstream, Eli, endothelial, eventually, FASB, feasibility, Fig, fire, Francisco, gait, GenVec, GR, gradually, Grand, inactivate, industrialization, infused, injectable, ischemic, joining, kill, killer, leave, Lilly, Melinda, messenger, mild, moderate, movement, multiforme, neuropathic, nigra, Nonmonetary, Note, opposition, ordered, PD, peripheral, placebo, plasmid, promise, receipt, regional, released, remeasured, remeasurement, renewed, requested, retire, revised, revocation, rigidity, San, satisfy, substantia, swelling, talking, thirty, trained, transaction, transiently, transmitting, trunk, UCSF, UK, unproven, vascular, walking, withdraw
Filing tables
Filing exhibits
Related press release
SGMO similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-179635, 333-174034, 333-166220, 333-157733, 333-132823, 333-64642 and 333-34196) and in the Registration Statement (Form S-3 No. 333-179634) and in the related prospectuses of Sangamo BioSciences, Inc. of our reports dated February 26, 2013, with respect to the consolidated financial statements of Sangamo BioSciences, Inc., and the effectiveness of internal control over financial reporting of Sangamo BioSciences, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2012.
/s/ Ernst & Young LLP
San Jose, California
February 26, 2013